iTeos Therapeutics, Inc. (NASDAQ:ITOS) Given Average Rating of “Hold” by Brokerages
Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) have earned an average rating of “Hold” from the seven brokerages that are covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price target […]
Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) have earned an average rating of “Hold” from the seven brokerages that are covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price target […]
